Healthcare Industry News: MOSAIQ Oncology
News Release - August 6, 2010
Elekta's MOSAIQ Oncology Information System for Cancer Management Receives Surescripts Certification for E-PrescribingATLANTA, Aug. 6 -- (Healthcare Sales & Marketing Network) -- With health care providers' desire to increase accuracy, lower costs and increase efficiency, e-prescription use in the United States is exploding. Surescripts® reports that by the end of 2009, approximately 18 percent of eligible prescriptions were prescribed electronically compared with just 6.6 percent at the end of 2008. And, the number of prescriptions routed electronically jumped from 68 million in 2008 to 191 million in 2009. Acknowledging this trend, Elekta applied for and received Surescripts certification for its MOSAIQ® oncology information system.
Operating the nation's largest e-prescribing network, Surescripts connects prescribers to their choice of e-prescribing software to pharmacies. Clinics and medical centers using MOSAIQ (v 2.2 and higher) can electronically route prescriptions to independent and chain-based pharmacies in the Surescripts network.
"Exchanging prescription information electronically between subscribers and pharmacies improves the accuracy of the prescribing process and saves time," says Donna Getreuer, RN, MSN, CTR and Director of Medical Oncology Business Marketing for Elekta. "Time-savings result primarily from reduced pharmacy phone calls and faxes related to prescription renewal authorizations and from a reduced need for pharmacy staff to key in prescription data."
E-prescribing supports HITECH Act criteria
As part of the Health Information Technology for Economic and Clinical Health (HITECH) Act, federal funds are available as incentives for centers that use EMR systems in a meaningful way.
"The cost-savings and workflow efficiencies of e-prescribing support the HITECH Act's meaningful use criteria," Getreuer says.
Surescripts' e-prescribing capabilities are fully integrated within the MOSAIQ EMR. Additional benefits include:
* Streamlined workflow to improve process efficiency and ensure high quality patient care.
* Physician time-savings with easy to use oncology-specific capabilities
* Real-time communications between doctors, pharmacies and patients
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.
Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives, making the future possible.
Today, Elekta solutions in oncology and neurosurgery are used in over 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group.
Elekta employs around 2,500 employees globally. The corporate headquarter is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. For more information about Elekta, please visit www.elekta.com.
Surescripts operates the nation's largest e-prescription network and supports a rapidly expanding ecosystem of health care organizations nationwide. Surescripts was founded on the principles of neutrality, transparency, interoperability, efficiency, collaboration and quality. Surescripts connects prescribers in all 50 states through their choice of e prescribing software to the nation's leading payers, chain pharmacies and independent pharmacies.
Available during emergencies or routine care, the Nation's E-Prescription Network gives health care providers secure, low-cost, electronic access to prescription and health information that can save their patients' lives, improve efficiency and reduce the cost of health care for all. For more information, go to www.surescripts.com.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.